| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/22/2001 | WO2001019795A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | WO2001019793A1 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same |
| 03/22/2001 | WO2001019792A1 Covalently linked dimeric dna binding molecules |
| 03/22/2001 | WO2000061134A8 Antimicrobial agents |
| 03/22/2001 | WO2000035435A9 Use of a mek inhibitor for preventing transplant rejection |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | DE19944993A1 Metallorganische Katalysatoren für die Polymerisation ungesättigter Verbindungen Organometallic catalysts for the polymerization of unsaturated compounds |
| 03/22/2001 | DE19944332A1 Antikonvulsiv und anxiolytisch wirkende 4-Amino-1-aryl-1,5-dihydro-pyrrol-2-one und Verfahren zu deren Herstellung Anticonvulsant and anxiolytic 4-amino-1-aryl-1,5-dihydro-pyrrol-2-one and processes for their preparation |
| 03/22/2001 | CA2384247A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | CA2382149A1 Fluorescent maleimides and uses thereof |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1085009A1 Indan derivatives |
| 03/21/2001 | EP1085000A1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 03/21/2001 | EP1084269A1 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 03/21/2001 | EP1084119A1 Aromatic amine derivatives as pharmaceutical agents |
| 03/21/2001 | EP1084107A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 03/21/2001 | EP1084106A1 N-linked sulfonamides of heterocyclic carboxylic acids or carboxylic acid isosteres |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083899A1 METHOD OF ENHANCING LYSOSOMAL $g(a)-GALACTOSIDASE A |
| 03/21/2001 | EP1083897A1 Hiv integrase inhibitors |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP1083876A1 Small molecule sulfonamide hair growth compositions and uses |
| 03/21/2001 | EP1083875A1 Small molecule carbamate or urea hair growth compositions and uses |
| 03/21/2001 | EP0599886B1 Macromonomers having reactive end groups |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/21/2001 | CN1288377A Patassium channel activators |
| 03/20/2001 | US6204293 Inhibitors of protein isoprenyl transferases |
| 03/16/2001 | CA2317257A1 4-amino-1-aryl-1,5-dihydropyrrol-2-ones having anticonvulsant and anxiolytic activity and processes for their preparation |
| 03/15/2001 | WO2001018002A1 Process for production of naphthyridine-3-carboxylic acid derivatives |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017980A1 Novel processes for preparing oxazepine derivatives |
| 03/15/2001 | WO2001017972A2 Novel herbicides |
| 03/15/2001 | WO2001017961A2 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives |
| 03/15/2001 | WO2001017956A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | WO2001017955A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2000058286A3 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 03/15/2001 | WO2000049007A8 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2381581A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/14/2001 | EP1082314A1 New dipeptidyl peptidase iv effectors |
| 03/14/2001 | EP1082304A1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) |
| 03/14/2001 | EP1082303A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082301A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 03/14/2001 | EP1082300A1 3-[(1'-n-methylamino)ethyl-n-benzyl]pyrrolidine monomethanesulfonate |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/13/2001 | US6201132 Inhibitors of membrane-bound serine protease; aminoacyl compounds |
| 03/13/2001 | US6201033 Improving compressive strength and/or airflow of a flexible polyurethane foam by reaction of a polyisocyanate with a polyol and water as blowing agent catalyzed by a tertiary amine free of urea groups and a urea compound |
| 03/13/2001 | US6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 03/13/2001 | US6201006 Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 03/13/2001 | US6200979 Administering substituted pyrazoles and pyzazolopyrimidines for treating phobias obsessive-compulsive disorder, post-traumatic stress disorder, single episode depression, recurrent depression, dysthymia, bipolar disorders |
| 03/13/2001 | US6200967 Used as thrombin inhibitors, coagulation inhibitors and agents for the treatment of thromboembolic disorders |
| 03/13/2001 | US6200353 Coupler for use in oxidative hair dyeing |
| 03/08/2001 | WO2001016141A1 Solid state laser dyes and methods of using the same |
| 03/08/2001 | WO2000063169A3 N-dimethyl amino ethanol carboxylate pyrrolidone hydrate in its crystallised form |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | WO1999039704A8 Antibacterial agents |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/07/2001 | EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080072A1 2-(2-chlorophenyl)-3,4-dihydro-2h-pyrrol derivatives |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP0839132B1 Novel process for the production of amorphous [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 03/07/2001 | EP0734379B1 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof |
| 03/07/2001 | EP0641325B1 Retroviral protease inhibitors |
| 03/07/2001 | CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof |
| 03/06/2001 | US6197974 Enantioselective synthesis of 3-aminopyrrolidines |
| 03/06/2001 | US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197770 Alkenyl- and alkynl-containing metalloprotease inhibitors |
| 03/06/2001 | CA2223081C Heterocyclic ring-fused pyrimidine derivatives |
| 03/06/2001 | CA2073673C Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors |
| 03/01/2001 | WO2001014576A2 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 03/01/2001 | WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 03/01/2001 | WO2001014348A1 Formation of heterocycles |
| 03/01/2001 | WO2001014329A1 Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates |
| 03/01/2001 | WO2001014328A2 Substituted ureas as cell adhesion inhibitors |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014316A1 Substituted chiral allosteric hemoglobin modifiers |
| 03/01/2001 | WO2000073270A8 Remedies for periodontal diseases |
| 03/01/2001 | WO2000071516B1 INHIBITORS OF FACTOR Xa |
| 03/01/2001 | WO2000030638A9 Drugs and reagents containing n-acyloxylated cycloalkyl compounds as the active ingredient |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |